fb tracking

WSJ Letter: Taxpayers Had a Role in the Development of Remdesivir

On May 7, 2020, Public Citizen responded to a Wall Street Journal Editorial on remdesivir. The letter notes that “in lavishing praise on the pharmaceutical industry, the editorial board overlooks a crucial author in the story of remdesivir: the taxpayer.” The letter describes how remdesivir has benefited from public funding at every turn. The full text is available here.